X0306 4 2022-03-15 0 0001479290 Revance Therapeutics, Inc. RVNC 0001359089 Joshi Abhay C/O REVANCE THERAPEUTICS, INC. 1222 DEMONBREUN STREET, SUITE 2000 NASHVILLE TN 37203 0 1 0 0 COO, President of R&D Common Stock 2022-03-15 4 F 0 2607 15.79 D 120708 D Represents the number of shares withheld by and surrendered to the Issuer on March 15, 2022, to satisfy tax withholding obligations that arose in connection with the vesting of Restricted Stock award (the "RSA") for 22,620 shares. The RSA vests in three equal annual installments from March 15, 2021, subject to Dr. Joshi's Continuous Service (as defined in the Issuer's 2014 Equity Incentive Plan) on each vesting date. /s/ Terri McDowell, Attorney-in-Fact 2022-03-17